Figure 4From: Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled studyEffect of six month therapy with trimetazidine or placebo on left ventricular diastolic function evaluated by the E/A wave ratio on mitral Doppler flow. A significant improvement in diastolic function was noted in patients receiving trimetazidine while no change was noted in patients allocated to standard care and placeboBack to article page